发明名称 BTK INHIBITORS
摘要 The present invention provides 6-5 membered fused pyridine ring compounds according to Formula I or pharmaceutically acceptable salts thereof. or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 membered fused pyridine ring compounds in the treatment of Bruton's Tyrosine Kinase (Btk) mediated disorders.
申请公布号 KR20140068020(A) 申请公布日期 2014.06.05
申请号 KR20147003924 申请日期 2012.07.19
申请人 MERCK SHARP & DOHME CORP.;MERCK SHARP & DOHME B.V. 发明人 DE MAN ADRIANUS P.A.;STERRENBURG JAN GERARD;RAAIJMAKERS HANS C.A.;KAPTEIN ALLARD;OUBRIE ARTHUR;REWINKEL JOHANNES B.M.;JANS CHRISTIAAN G.J.M.;WIJKMANS JACOBUS C.H.M;BARF TJEERD A.;COOPER ALAN B.;KIM RONALD M.;BOGA SOBHANA BABU;ZHU HUGH Y.;GAO XIAOLEI;YAO XIN;ANAND RAJAN;WU HAO;LIU SHILAN;YANG CHUNDAO;ALHASSAN ABDUL BASIT;WANG JAMES;YU YOUNONG;LIU JIAN;VACCARO HENRY M.
分类号 C07D487/04;A61K31/437;A61K31/4985;A61P3/10;C07D401/10;C07D403/10 主分类号 C07D487/04
代理机构 代理人
主权项
地址